“…Bone grafting intervention is of particular importance for the repair of critical-sized bone defects that cannot be regenerated on their own . As an alternative to autografts and allografts with unsatisfactory clinical limitations, bone tissue engineering offers an attractive therapeutic option for bone augmentation, − which effectively regulates immunity, vascularization, and neurogenesis. − A central hotspot is guided bone regeneration based on scaffolds that provide physicochemical and biological cues for facilitating cellular adhesion, proliferation, migration, and differentiation. − With the merits of good biocompatibility, biodegradability, and favorable mechanical properties, synthetic biomedical polymers, such as poly(ε-caprolactone) (PCL), poly(lactic acid), poly(lactic- co -glycolic acid), and poly(hydroxybutyrate) have become the biomaterials of choice for bone repair scaffolds. − However, biomedical polymer scaffolds suffer from shortcomings in terms of osteoconductivity, osteoinductivity, and osteoengineering, posing a critical unmet challenge.…”